Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01529047 · ClinicalTrials.gov registry record · NA
Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling
A NA study of Cannabis and Alcohol Consumption, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 361
- Enrollment target
- 1
- Study location
NCT01529047: Completed NA study of Cannabis and Alcohol Consumption, sponsored by University of Washington.
NCT01529047 is a NA study of Cannabis and Alcohol Consumption that has completed, run by University of Washington. The registered enrollment target is 361 participants, above the 96-participant average among 24 other Cannabis trials with a reported enrollment target (276% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01529047, a NA study of Cannabis and Alcohol Consumption, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 361 participants
- Enrollment target
- 1
- Study location
Study Summary
Rates of gambling and substance use behaviors are elevated among emerging adults (ages 18-24), and these behaviors are individually and jointly associated with a host of negative consequences. Evidence suggests there is significant overlap between these behaviors as well as comorbidity of associated mental disorders (i.e., pathological gambling and substance abuse/dependence). Prior research suggests that a brief in-person delivered personalized feedback intervention (PFI) may be an effective method of reducing these behaviors and their associated consequences among emerging adults. Thus, the purpose of this study is to determine the relative efficacy of an in-person delivered PFI versus a Web-based PFI in reducing gambling, alcohol and marijuana use behaviors and related-consequences in a sample of emerging adults, as well as explore potential moderators and mediators of intervention efficacy and the longevity of intervention effects (over a period of 18-months).
Conditions Studied
Interventions
- BEHAVIORAL Personalized Feedback Intervention
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2010-02 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT01529047 record still lists
NCT01529047 is an interventional study that assigns participants to a tested intervention. The registered 361 participants enrollment target is mid-sized for trials with a published cap, above the 96-participant average among 24 other Cannabis trials with a reported enrollment target (276% higher).
The record links to 3 conditions, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which Personalized Feedback Intervention is the first listed.
NCT01529047 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01529047 about?
NCT01529047 is a clinical study titled "Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling". Rates of gambling and substance use behaviors are elevated among emerging adults (ages 18-24), and these behaviors are individually and jointly associated with a host of negative consequences. Evidence suggests there is significant overlap between these behaviors as well as comorbidity of associated...
What is the current status of trial NCT01529047?
This trial is currently completed. It is a NA study. The enrollment target is 361 participants. The study started on 2010-02. Estimated completion is 2015-01.
What conditions does trial NCT01529047 study?
This clinical trial studies the following conditions: Cannabis, Alcohol Consumption, Gambling.
What interventions are being tested in trial NCT01529047?
The interventions under investigation include: Personalized Feedback Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01529047?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01529047 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01529047's enrollment target sits among peer trials
361 2nd of 24 the highest of 24 other Cannabis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
RECRUITING · NA
-
Impact of Reduced Cannabis Use on Functional Outcomes (R33 Phase)
COMPLETED · NA
-
Families With Substance Use and Psychosis: A Pilot Study
COMPLETED · NA
-
Intervening to Prevent Youth Access to Marijuana Phase II
COMPLETED · NA
-
Feasibility Trial of rTMS for Cannabis Use Disorder
COMPLETED · NA
-
Pain Inflammation and Cannabis in HIV
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05533697 · 361 participants · Phase 1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia